Ankit Aggarwal is an Executive Director at J.P. Morgan in New York, where he leads capital markets and strategic advisory for ...

Bayer’s Vividion Therapeutics has secured the global rights from its partner Roche to the only Werner helicase (WRN) inhibitor to have made it into the clinic.

Merck held talks over a potential $3 billion acquisition of MoonLake Immunotherapeutics, as it seeks to replenish its drug pipeline ...

Following a ~7% rise in the previous session, AnaptysBio (NASDAQ:ANAB) extended gains in the premarket on Wednesday after the ...